Login To Trade  |  About IIFL
  • NIFTY  8152.9  33.6 0.41%
  • SENSEX 26932.88  147.33 0.55%
Avon Lifesciences Ltd

BSE: 531541 | NSE: ISIN: INE881A01015
Market Cap: [Rs.Cr.] 118.69 Face Value: [Rs.] 10
Industry: Chemicals

Watchlist +
Director's Report


The Members,

Your Directors have pleasure in presenting their Twentieth Annual Report on the business and operations of the Company and the Audited Financial Accounts for the year ended 31st March, 2013.


Particulars 2012-13 2011-12
(Rs. in Lakhs) (Rs. in Lakhs)
Sales & Operational Income 17015.04 16703.34
Gross Profit /(Loss) before Interest, Depreciation and Tax (PBDIT) 3596.74 4175.69
Less. Depreciation 996.51 1086.09
Gross Profit before Interest and Tax (PBIT) 2600.23 3089.60
Less. Financial charges 1720.82 1954.32
Profit 1 (Loss) before Tax (PBT) 879.41 1135.28
Less Provision for Taxation: Provision for tax 200.00 222.00
Add: MAT credit (200.00) (222.00)
: Short provision for Tax for earlier years - 76.76
: Deferred Tax 51.97 51.97
Net Profit / (Loss) after Tax (PAT) 827.44 1006.55

Previous Year's figures have been regrouped/ reclassified wherever necessary to conform to the current year's classification.


In order to conserve available financial resources, your Directors do not recommend any dividend on Equity Shares for the year under review.


During the year, the Company has achieved Net Sales and Operational income of Rs. 17015.04 Lakhs as against Rs. 16703.34 Lakhs in the previous year, registering an increase in sales by 1.87%. The Company has achieved a Net Profit of Rs.827.44 Lakhs as against Rs. 1,006.55 Lakhs during the previous fiscal year.

During the year under review the export turnover amounting to Rs.3716.64 Lakhs constituted 21.84% of the total turnover vis-a-vis Rs. 5202.26 Lakhs, constituting 31.15% achieved in the previous year.


During the year under review, Capital work in progress amounting to Rs. 1349.07 Lakhs was capitalized and in addition Rs. 492.64 Lakhs was incurred on maintenance capex.


The Company continues with its efforts to maintain highest quality standards and complies with various regulations as required by laws for supplies of products to various territories. The Company currently has following valid certifications:

• ISO 9001:2008

• The Solapur unit of the Company is cGMP compliant and is USFDA inspected.


As a defining step in the cost control and operational optimization exercise, the Company at its Board meeting held on 9th August, 2013, has decided to shift complete manufacturing operations from the unit at Sadasivpet near Hyderabad to Solapur unit, Maharashtra. The consolidation of operations is expected to yield a considerable savings in operational cost.


Pursuant to the provisions of Section 217 (2AA) of the Companies Act, 1956, the Directors confirm that:

a) In the preparation of the annual accounts for the year ended 31s' March, 2013, the applicable accounting standards have been followed along with proper explanation relating to material departures;

b) Your Directors have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the company as at 31st March, 2013 and of the Profit and Loss Account forthe year ended on that date;

c) Your Directors have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the Assets of the company and preventing and detecting fraud and other irregularities; and

d) The accounts for the year ended 31s1 March, 2013 have been prepared on a going concern basis.


The Company strives to ensure that the best corporate governance policies and practices are consistently followed. It is the continuous endeavour of the Company to sustain such corporate governance standards at all levels through the company. The specific report on Corporate Governance, included in this Annual Report, states the exact nature of compliances made by the Company during the year under review. A certificate from Chairman and Managing Director of the Company, inter alia, confirming the correctness of the financial statements, compliance with company's code of conduct, adequacy of internal control measures and reporting of the matters to the Audit Committee in terms of Clause 49 of the Listing Agreements entered into by the Company with Stock Exchanges, is also enclosed as a part of this Annual Report.


The Company acquired 10% stake from the promoter shareholders to make Regal Pharma Pte. Ltd., a wholly owned subsidiary of Avon Organics Limited. Your company gets assistance in marketing operations in the overseas market.


The Ministry of Corporate affairs vide its General Circular no. 2/2011 dated 8"1 February, 2011 has granted a general exemption from appending the balance sheet of subsidiary companies to the annual report of the parent company as per Section 212 (8) of the Companies Act, 1956. As required under the circular, the Board of Directors of the

Company, has, at its meeting held on 30th May, 2013, passed a resolution issuing consent for not attaching the Balance Sheet of Subsidiary company to this Annual Report. Accordingly, the Balance Sheet, Profit & Loss Account and other documents of the subsidiary company are not being appended with the Balance Sheet of the Company.

The Company will arrange for the Annual Accounts of the subsidiary company and other relevant information in detail, for any shareholder of the Company who may be interested in obtaining the same.

The consolidated financial statements as prepared in accordance with the requirements of AS 21 and AS 23 issued by ICAI, and a statement pursuant Section 212 of the Companies Act, 1956 are appended to and are forming part of this annual report.


The Board has an optimum combination of Executive and Non-Executive Directors.

As per the requirements of Clause 49 of Listing Agreement, the Non-Executive Chairman, being a Promoter Director of the parent Company, fifty percent of the Board comprises of Independent Directors, in compliance with the provisions of Clause 49 of the Listing Agreement.

Details of Directors re-appointed during the year

Mr. Ajit Kamath, Non-Executive Chairman & Managing Director retires by rotation at the ensuing Annual General Meeting and being eligible, offers himself for re-appointment.

Mr. Manoj Jain, Non-Executive Director retires by rotation at the ensuing Annual General Meeting and being eligible, offers himself for re-appointment.

Details of Director appointed as Additional Director during the year

Mr. Rajendra Kaimal, appointed as Additional Director at the Meeting of the Board of Directors held on 30th May, 2013, is proposed to be confirmed at the Annual General Meeting of the Company.

Brief profiles of the abovementioned Directors are included in a separate Annexure after the Notice, forming part of this Annual Report.


The Board of Directors commends the continued dedication of employees at all levels and the industrial relations continue to be peaceful and cordial. Your Company's dedicated and talented workforce has enabled it to remain at the forefront of the Industry.

Section 217 (2A) of the Companies Act, 1956 read with Companies (Particulars of Employees) Rules, 1975 as amended, requires Companies to list out names of the employees drawing remuneration of more than Rs. 5 Lakhs per month and/or more than Rs. 60 Lakhs Perannum.

However, none of the employees of the Company drew remuneration of Rs. 60 Lakhs or above per annum and/or Rs. 5 Lakhs or above per month during the year under review.


IWs. Mukesh Mehta & Co., Chartered Accountants, Statutory Auditors of the Company, continue to hold office until conclusion of this Annual General Meeting and are recommended for re-appointment upto the conclusion of next Annual General Meeting. In terms of Clause 41(1)(h) of the Listing Agreement, the Statutory Auditors of the Company are subjected to the Peer Review Process of Institute of Chartered Accountants of India (ICAI), and hold a valid certificate issued by Peer Review Board of ICAI.


In compliance with the directives issued by Central Government from time to time and in terms of the provisions of Section 233B of the Companies Act, 1956, M/s. D.Z.R. & Co., Cost Accountants were appointed as Cost Auditors of the Company at the meeting of the Board of Directors held on 30th May, 2013 for the manufacturing units of the Company located at Solapur, Maharashtra and Sadasivpet, Andhra Pradesh, respectively. A certificate of eligibility has been received from M/s. D.Z. R. &Co., Cost Accountants, to the effect that their appointment is in accordance with the provisions of Section 224 (1) ? of the Companies Act, 1956.


The information relating to Energy Conservation, Technology Absorption and Foreign Exchange Earnings and Outgo as required to be disclosed under Section 217(1) (e) of the Companies Act, 1956 read with the Companies (Disclosure of Particulars in the Report of the Board of Directors) Rules, 1988 are set out as an annexure forming part of this Report.


During the year under review, the company has neither invited nor received any deposits from the public.


The Board of Directors take this opportunity to thank the Financial Institutions, Banks, employees, business associates, suppliers, Stock Exchanges, other regulatory authorities and all the stake holders of the Company for valuable sustained support and cooperation in conducting efficient operations of the Company. The Board also places on record the sustained management support received from M/s. Arch Pharmalabs Limited, the Parent Company.

For and on behalf of the Board
Place: Mumbai Ajit Kamath
Date: 09.08.2013 Chairman & Managing Director


Information under Section 217(1) (e) of the Companies Act, 1956 read with the Companies (Disclosure of Particulars in the Report of the Board of Directors) Rules, 1988

A. Conservation of Energy:
a. Energy Conservation Measures taken : The Company is engaged in continuous process of energy conservation through improved operational and maintenance practices.
b. Total energy consumption per unit of Production : Details are furnished in Form A
B. Technology absorption : Details are furnished in Form ?

?. Foreign Exchange Earnings and Outgo

2012-2013 2011-2012
1. Foreign Exchange Earnings (Rs. In Lacs) 3716.64 5202.26
2. Foreign Exchange outgo (Rs.in Lacs) 1613.67 1250.04
3. Net Foreign Exchange Earnings (Rs. In Lacs) 2102.97 3952.22


Form for disclosure of particulars with respect to conservation of energy.

2012-2013 2011-2012
a. Purchased Units: 6422148 8816645
Amount (Rs. In lacs) 466.28 487.78
Rate/Unit (Rs.) 7.26 5.53
b. Own Generation:
Through D. G. Set Units 262155 837074
Amount (Rs. In lacs) 40.85 121.21
Rate/Unit (Rs.) 15.58 14.48
2. FURNACE & BOILER (Rs. In lacs) 345.18 570.86
Electricity (Unit/MT)(Rs.) 392076 204565
Furnace & Boiler (Unit /??) (Rs.) 266868 191757



1. Specific areas in which R&D was carried out.

CEFDINIR intermediate - Laboratory trials are completed and are ready to be implemented in plant.

2. Benefits derived from above R&D.

CEFDINIR intermediate is being considered for production at a commercial level.

3. Future plan of action.

To achieve maximum production of DEAA (Di ethyl aceto acetamide) and CEFDINIR intermediate.

4. Expenditure on R & D:

(Rs. In lacs)
2012-13 2011-12
Revenue Expenditure 32.93 39.17
% to Turnover 0.19% 0.23%


1. Efforts in brief made towards technology absorption Consistent efforts made towards achieving the required quality of Pseudoephedrine Hydrochloride.
2. Benefits derived as a result of the above efforts, e.g. product improvement, cost reduction, product development, import substitution etc. Cost reduction in Pseudoephedrine Hydrochloride.
3. In case of imported technology (import during the last 5 years reckoned from the beginning of the year); following information may be furnished
a Technology imported Nil
b Year of import Not Applicable
? Has technology been fully absorbed Not Applicable
India Infoline Research
No Related Research Found
Related News
No Related Research Found
Futures & Options Quote
Future Data Not present
Key Information

Key Executives:

Ajit Kamath , Chairman & Managing Director

Manoj Jain , Whole-time Director

Rajendra Kaimal , Director

Jignesh Patel , Company Secretary

Company Head Office / Quarters:

Survey No 18 Yawapur Village,
Sadasivpet Mandal,
Andhra Pradesh-502291
Phone : Andhra Pradesh-91-9949828084 / Andhra Pradesh-
Fax : Andhra Pradesh-91-40-23404438 / Andhra Pradesh-
E-mail :
Web :


XL Softech Systems Ltd
Plot No 3 Sagar Soci,Road No 2,Banjara Hills,Hyderabad - 500034

Fund Holding
Scheme Name No. of Shares
Mon Tue Wed Thu Fri Sat Sun
22 23 24 25 26 27 28